Fc-binding protein acid stability via amino acid substitution

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Wild-type human FcγRIIa lacks sufficient acid stability, which is a limitation for industrial applications and storage.

Innovation Solution

Specific amino acid substitutions and deletions in the Fc-binding protein, such as Leu190Ser, improve acid stability, and the protein is produced using a method involving error-prone PCR and immobilized on an insoluble carrier for antibody adsorption.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If wild-type human FcγRIIa is used, then the protein maintains natural binding function, but acid stability is insufficient for industrial applications

Engineering Contradiction:
Improveacid stabilityVSAvoidindustrial applicability
Core Design Contradiction:
ReliabilityVSEase of manufacture

Solution Approach 1:

The patent applies parameter changes by substituting specific amino acid residues (e.g., L190S, L63P, Q69L, P83L, I45T, T123P, N75S) in the FcγRIIa protein sequence to improve acid stability. These point mutations modify the protein's chemical properties without fundamentally changing its structure or function, enabling industrial application while maintaining natural binding function.

Inventive Principle:
Principle #35Parameter changes

2Reliability

If multiple amino acid substitutions are introduced to improve acid stability, then acid resistance increases, but protein structure complexity increases

Engineering Contradiction:
Improveacid resistanceVSAvoidprotein structure complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The patent applies local quality by introducing amino acid substitutions at specific, localized positions (e.g., positions 190, 63, 69, 83, 45, 123, 75) rather than throughout the entire protein sequence. This targeted approach improves acid stability while minimizing overall structural complexity and maintaining the protein's fundamental architecture.

Inventive Principle:
Principle #3Local quality

Data Source

PatentUS20210002367A1Fc-binding protein having improved acid stability, production method for said protein, and antibody-adsorbing agent using said protein
Publication Date: 2021.01.07 TOSOH CORP
  • US20210002367A1 patent drawing

AI summary

An Fc-binding protein having at least amino acid residues of the extracellular domain of the amino acid sequence of wildtype human FcγRIIa (UniProt Accession Number: P12318) wherein the amino acid residues in the domain have an amino acid substitution or deletion at at least a specific position, a method for producing the protein, and an antibody adsorbent using the protein.